BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bhatt A, Wu J. Immunotherapy for recurrent hepatocellular carcinoma. World J Gastroenterol 2023; 29(15): 2261-2271 [PMID: 37124885 DOI: 10.3748/wjg.v29.i15.2261]
URL: https://www.wjgnet.com/1007-9327/full/v29/i15/2261.htm
Number Citing Articles
1
Boping Li, Shuang Wang, Baihui Shan, Baizhi Li, Fuqiu Li. A PD-L1xCD3 bispecific nanobody as a novel T-cell engager in treating PD-L1 overexpression melanomaMolecular Immunology 2023; 163: 20 doi: 10.1016/j.molimm.2023.09.005
2
Grigorios Papadopoulos, Eirini Giannousi, Aikaterini P. Avdi, Rallia-Iliana Velliou, Polyxeni Nikolakopoulou, Antonios Chatzigeorgiou. Τ cell-mediated adaptive immunity in the transition from metabolic dysfunction-associated steatohepatitis to hepatocellular carcinomaFrontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1343806
3
Junning Liu, Guangnian Zhang, Linfeng Yang, Duan Yan, Jiahui Yu, Song Wei, Jijiang Li, Pengsheng Yi. Salvage liver transplantation versus curative treatment for patients with recurrent hepatocellular carcinoma: A systematic review and meta-analysisEuropean Journal of Surgical Oncology 2024; 50(7): 108427 doi: 10.1016/j.ejso.2024.108427
4
Xianling Wang, Yan Yang, Shuang Zhao, Di Wu, Le Li, Zhifeng Zhao. Chitosan-based biomaterial delivery strategies for hepatocellular carcinomaFrontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1446030
5
Yusra Zarlashat, Shakil Abbas, Abdul Ghaffar. Hepatocellular Carcinoma: Beyond the Border of Advanced Stage TherapyCancers 2024; 16(11): 2034 doi: 10.3390/cancers16112034
6
Jin-You Guo, Li-Li Zhao, Hui-Jun Cai, Hui Zeng, Wei-Dong Mei. Radiofrequency ablation combined with transcatheter arterial chemoembolization for recurrent liver cancerWorld Journal of Gastrointestinal Surgery 2024; 16(6): 1756-1764 doi: 10.4240/wjgs.v16.i6.1756
7
Yu-Tang Chen, Bo-Wen-Tao Chen, Jun-Ming Xu, Xiao-Cui You, Yi Tang, Shao-Jie Wu, Zhu-Ting Fang. Multicenter Study on Transarterial Chemoembolization Combined with Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma: Primary versus Recurrent HCCJournal of Hepatocellular Carcinoma 2024; : 2441 doi: 10.2147/JHC.S497956